Product Showcase

Omeprazole and Sodium Bicarbonate Capsules launched

Ajanta Pharma USA Inc., a wholly owned subsidiary of Ajanta Pharma Ltd, announced the launch of Omeprazole and Sodium Bicarbonate Capsules (20mg/1100mg and 40mg/1100mg), a bioequivalent prescription generic version of Zegerid Capsules.

Ajanta Pharma USA Inc., a wholly owned subsidiary of Ajanta Pharma Ltd, announced the launch of Omeprazole and Sodium Bicarbonate Capsules (20mg/1100mg and 40mg/1100mg), a bioequivalent prescription generic version of Zegerid Capsules.

Ajanta Pharma

Omeprazole and Sodium Bicarbonate Capsules is part of an ever-growing portfolio of products that Ajanta has developed for the U.S. market. In total, Ajanta has 26 Abbreviated New Drug Applications (ANDAs) of which it has 11 final ANDA approvals; 1 tentative approval; and 14 ANDAs under review with the United States Food & Drug Administration (FDA).

To Top